Table of Contents Table of Contents
Previous Page  737 / 1631 Next Page
Information
Show Menu
Previous Page 737 / 1631 Next Page
Page Background

Duvelisib

Douglas ASH 2013

Optimal biological dose

25mg bd continuously

Expansion cohort (Flinn

et al ASH 2014)(=31)

ORR 65%

5 complete responses,

all follicular lymphoma

1 … 732 733 734 735 736 737 738 739 740 741 742 743 … 1631  FlippingBook